MET Immunohistochemistry Should Be Avoided in Selecting Non-small-cell Lung Cancers Requiring MET Exon 14 Skipping Mutation Analysis

被引：5
|
作者：
Lambros, Laetitia [1 ]
Uguen, Arnaud [1 ,2 ]
机构：
[1] CHRU Brest, Dept Pathol, Brest, France
[2] INSERM, U1053 BaRITOn, Bordeaux, France
来源：
CLINICAL LUNG CANCER | 2019年 / 20卷 / 03期
关键词：
D O I：
10.1016/j.cllc.2018.12.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E418 / E420
页数：3
相关论文
共 50 条
  • [31] Adenosquamous carcinoma of the lung - biopsy: MET exon 14 skipping mutation
    Sousa, V.
    Alarcao, A.
    Ladeirinha, A.
    Silva, M. Reis
    Ferreira, T.
    Rodrigues, A.
    Vilasboas, C.
    Carvalho, L.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S333 - S333
  • [32] Lung adenocarcinoma with MET exon 14 skipping mutation; clinicopathological characteristics and immunohistochemical MET expression
    Motoi, Noriko
    Sunami, Kuniko
    Ohe, Yuichiro
    Watanabe, Shun-ichi
    Kohno, Takashi
    LABORATORY INVESTIGATION, 2018, 98 : 742 - 742
  • [33] Lung adenocarcinoma with MET exon 14 skipping mutation; clinicopathological characteristics and immunohistochemical MET expression
    Motoi, Noriko
    Sunami, Kuniko
    Ohe, Yuichiro
    Watanabe, Shun-ichi
    Kohno, Takashi
    MODERN PATHOLOGY, 2018, 31 : 742 - 742
  • [34] MET Exon 14 Skipping Mutation in Non-Small Cell Lung Cancer (NSCLC) by Specific Mutation, Histology, and Smoking History
    Marks, J.
    Yin, J.
    Halmos, B.
    Bazhenova, L.
    Ramalingam, S. S.
    Marmarelis, M. E.
    Xiu, J.
    Walker, P.
    Oberley, M.
    Ma, P. C.
    Liu, S. V.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S61 - S61
  • [35] Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14-skipping mutation: A series of 6 cases
    Mayenga, Marie
    Assie, Jean-Baptiste
    Monnet, Isabelle
    Massiani, Marie-Ange
    Tabeze, Laure
    Friard, Sylvie
    Fraboulet, Severine
    Metivier, Anne-Cecile
    Chouaid, Christos
    Zemoura, Leila
    Longchampt, Elisabeth
    Callens, Celine
    Melaabi, Samia
    Couderc, Louis-Jean
    Doubre, Helene
    LUNG CANCER, 2020, 150 : 21 - 25
  • [36] MET targeted therapy in non-small cell lung cancer patients with MET exon 14-skipping mutations
    Jorgensen, Jan Trost
    Urbanska, Edyta M.
    Mollerup, Jens
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (04) : 940 - 946
  • [37] Phase II Trial of Ensartinib for Advanced or Metastatic Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
    Xia, Y.
    Zhou, M.
    Tian, P.
    Zhao, J.
    Jin, Y.
    Guo, Z.
    Miao, D.
    Lu, Y.
    Le, X.
    Zhang, Y.
    Li, W.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S76 - S77
  • [38] Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib
    Paik, Paul K.
    Goyal, Ravi K.
    Cai, Beilei
    Price, Mark A.
    Davis, Keith L.
    Ansquer, Valerie Derrien
    Caro, Nydia
    Saliba, Teddy R.
    FUTURE ONCOLOGY, 2023, 19 (03) : 217 - 228
  • [39] Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations
    Huang, Caiwen
    Zou, Qihua
    Liu, Hui
    Qiu, Bo
    Li, Qiwen
    Lin, Yongbin
    Liang, Ying
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (04)
  • [40] Management of Non-small Cell Lung Cancer Patients with MET Exon 14 Skipping Mutations
    Caiwen Huang
    Qihua Zou
    Hui Liu
    Bo Qiu
    Qiwen Li
    Yongbin Lin
    Ying Liang
    Current Treatment Options in Oncology, 2020, 21
12345